Edition:
United States

Express Scripts Holding Co (ESRX.OQ)

ESRX.OQ on NASDAQ Stock Exchange Global Select Market

75.08USD
10:37am EST
Change (% chg)

$0.36 (+0.48%)
Prev Close
$74.72
Open
$75.33
Day's High
$76.03
Day's Low
$74.77
Volume
115,992
Avg. Vol
1,524,919
52-wk High
$83.49
52-wk Low
$55.80

Select another date:

Tue, Feb 20 2018

BRIEF-Express Scripts And Walgreens Boots Alliance Expand Group Purchasing Efforts To Include Specialty Brand Medications

* EXPRESS SCRIPTS AND WALGREENS BOOTS ALLIANCE EXPAND GROUP PURCHASING EFFORTS TO INCLUDE SPECIALTY BRAND MEDICATIONS

BRIEF-Express Scripts' Unit Says Offering Savings on Influenza Medications

* ‍INSIDE RX - OFFERING SAVINGS OF UP TO 25 PERCENT ON BRAND-NAME TAMIFLU, TO OFFER DISCOUNT OF UP TO 28 PERCENT ON GENERICS COMPARED TO RESPECTIVE CASH PRICES Source text for Eikon: Further company coverage:

Express Scripts unit beats charity donation whistleblower lawsuit

A federal appeals court on Friday upheld the dismissal of a whistleblower lawsuit claiming that a specialty pharmacy later acquired by Express Scripts Holding Co paid kickbacks disguised as charitable donations in exchange for patient referrals.

BRIEF-Express Scripts Holding Sees FY 2017 ADJ SHR $7.00 To $7.08

* EXPRESS SCRIPTS HOLDING COMPANY UPDATES 2017 FULL-YEAR GUIDANCE AND ANNOUNCES 2018 FINANCIAL GUIDANCE

Express Scripts forecast 2018 profit above estimates, shares rise

Pharmacy benefit manager Express Scripts Holding Co forecast full-year 2018 adjusted earnings on Thursday that topped analysts' expectations, helped by its ongoing acquisition of eviCore Healthcare.

UPDATE 1-Express Scripts forecast 2018 profit above estimates, shares rise

Dec 14 Pharmacy benefit manager Express Scripts Holding Co forecast full-year 2018 adjusted earnings on Thursday that topped analysts' expectations, helped by its ongoing acquisition of eviCore Healthcare.

Express Scripts 2018 earnings forecast above estimates

Dec 14 Pharmacy benefit manager Express Scripts Holding Co forecast full-year 2018 adjusted earnings on Thursday that topped analysts' expectations, helped by its ongoing acquisition of eviCore Healthcare.

Express Scripts CEO sees Amazon as a potential partner: CNBC

Express Scripts Holding sees Amazon.com Inc , which has been reported to be interested in entering the pharmacy market, as a possible partner rather than a competitor, the chief executive of the pharmacy benefit manager (PBM) said on Thursday on CNBC.

UPDATE 1-Express Scripts CEO sees Amazon as a potential partner-CNBC

Nov 30 Express Scripts Holding sees Amazon.com Inc, which has been reported to be interested in entering the pharmacy market, as a possible partner rather than a competitor, the chief executive of the pharmacy benefit manager (PBM) said on Thursday on CNBC.

Express Scripts CEO says he sees Amazon as a potential partner -CNBC

NEW YORK, Nov 30 Express Scripts Holding chief executive officer said on Thursday on CNBC that he sees Amazon Inc, which has been reported to be interested in entering the pharmacy market, as a possible partner for the pharmacy benefit manager rather than an outright competitor.

Select another date: